Mass General Brigham, Inc

Position in MAZE — Maze Therapeutics, Inc.

CIK 1678378 SOMERVILLE, MA

Position in MAZE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$7,161,420

-$2,400 QoQ

Shares Held

239,994

0.0% QoQ

Ownership

0.432%

of shares outstanding

% of Portfolio

4.38%

of 13F equity value

Holder Rank

#42

of 161 holders

Holding Since

Dec 2025

3 quarters on record

Healthcare · as of Jun 30, 2026

Mass General Brigham, Inc holds $82,674,823 across 3 Biotechnology names. MAZE ranks #3 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	344,091	$64,441,362
2	TNGX	Tango Therapeutics, Inc.	354,192	$11,072,041
3	MAZE	Maze Therapeutics, Inc. This page	239,994	$7,161,420

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,161,420	239,994	0.0%	Shares	Sole	2026-08-07
2026-03-31	$7,163,820	239,994	0.0%	Shares	Sole	2026-05-05
2025-12-31	$9,942,951	239,994	—	Shares	Sole	2026-01-27
No filing history on record for this holder in this stock.